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Abstract 
Despite a wealth of studies on differences regarding the biobehavioral and social–psychological bases 
of mental disorders in men and women and repeated calls for increased attention, women-specific 
issues have so far not been comprehensively addressed in past diagnostic classification systems of 
mental disorders. There is also increasing evidence that this situation will not change significantly in 
the upcoming revisions of ICD-11 and DSM-V. This paper explores reasons for this continued failure, 
highlighting three major barriers: the fragmentation of the field of women's mental health research, 
lack of emphasis on diagnostic classificatory issues beyond a few selected clinical conditions, and 
finally, the “current rules of game” used by the current DSM-V Task Forces in the revision process of 
DSM-V. The paper calls for concerted efforts of researchers, clinicians, and other stakeholders within 
a more coherent and comprehensive framework aiming at broader coverage of women-specific 
diagnostic classificatory issues in future diagnostic systems.  
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Introduction: the evidence 
 
Over the past two decades, solid research findings have been presented highlighting the core 
relevance of female-specific factors in mental health. The evidence covers virtually all areas 
of interest ranging from biological and developmental factors, gender-specific differences on 
risk, protective and resilience factors, social stress, trauma and violence, the pathogenesis and 
natural course of specific mental disorders, as well as issues of identification, treatment and 
intervention, and public health. This evidence has also been repeatedly summarized and 
translated into a comprehensive agenda for action, for example, in the Surgeon General's 
Workshop on Women's Mental Health (2005) or the World Health Organization's mission 
statement on “Gender and Women's Mental Health” (2009). Thus, there is no doubt that 
gender is not only a critical determinant of mental health and mental disorders, including the 
existence of female-specific disorders with associated specific pathogenetic mechanisms, and 
there is also little doubt about the existence of gender-specific determinants and mechanisms 
promoting and protecting mental health. There is also clear evidence of a substantial public 
health impact, revealing that the disease burden resulting from mental disorders and 
neuropsychiatric condition is disproportionally higher in females compared to males. 
Depressive disorders in females alone account for 42% of all the disability burden from all 
neuropsychiatric disorders as opposed to 29.3% in males; even higher estimates for females of 
up to 65% have been estimated if the disease burden is measured for all mental disorders 
among subjects in the reproductive years (16–55; Wittchen and Jacobi 2005). Yet – despite 
this convergent evidence – it remains puzzling for many of us to find out that this evidence is 
not more comprehensively and specifically addressed in our manual definitions of specific 
mental disorders in the DSMIVTR (APA 1987) or ICD-10 (WHO 1993). Of course, it could 
be seen as a certain progress that, in the more recent DSM versions, core gender issues are 
now addressed within the text descriptions (chapters on “Specific culture and gender 
features”). However, female-specific diagnostic features are generally not specified as 
diagnostic criteria for specific disorders and, if they are, they are only mentioned as a specifier 
(as for mood disorders “with postpartum onset”) or removed to the appendix chapter on 
“Criteria sets and axes provided for further study” (as for premenstrual dysphoric disorder 
[PMDD]; American Psychiatric Association (APA) 2000). More importantly, there is little 
hope that this situation will change significantly in the upcoming revisions of ICD-11 and 
DSM-V. Despite the publication of a DSM-V mission book on age and gender considerations 
(Narrow et al. 2007) that highlights again the critical importance of gender in how mental 
disorders develop and present, there are up to now no signals of a systematic approach in the 
background documents for the DSM-V revision process to deal with female-specific disorders 
and syndromes more comprehensively and in greater detail. For example, neither the DSM-V 
mission book “A research agenda for DSM-V” (Kupfer et al. 2002) nor its follow-up 
publication “Advancing DSM – dilemmas in psychiatric diagnosis” (Phillips et al. 2003) do 
discuss this topic as a priority area and not even one chapter discusses specifically the 
challenges involved in gender issues and female-specific definitions of mental disorders. This 
leads us to the question of why do we seem to fail again to ensure a broader consideration of 
female-specific issues in our diagnostic classification system?  
 
 
Incorporating female-specific issues in DSM-V: why we might fail again 
 
Revising diagnostic classification systems: “the rules of the game” 
 
Revising a diagnostic classification system is a highly complex and largely political process. 
The “players” are not only the researchers and clinicians, but also the public and stakeholders. 
On this more general level, one major political barrier and obstacle might be seen in the fact 
that many advocacy groups oppose female-specific criteria, syndromes, and disorders because 
they fear that psychiatric stigma and associated adverse effects might be attached to the role 
of women and the problems they experience. Although since DSM-III this indeed quite 
critical issue has been moderated by introducing the more neutral and descriptive term of 
“mental disorders,” thus avoiding the highly problematic term “psychiatric illness,” this 
obviously did not moderate the sometimes fierce rejection of diagnostic categories like 
“premenstrual dysphoric disorder,” as an example. Beyond this more political issue, there are 
numerous other barriers, such as the constitution of revision task forces, rarely including 
experts on female-specific issues, and the removal of gender issues of diagnosis-specific task 
forces into a separate task force together with culture issues. Although such an organization 
seems to make a lot of sense because gender issues clearly represent a general concern that 
cut across all diagnoses, such separation makes it more difficult to reach agreement in the 
diagnostic task forces about gender-specific suggestions, simply because the linkages between 
task forces imply substantial logistical challenges. Another barrier might be that there are too 
many specific critical topics that are being addressed (e.g., improving the wording of criteria 
of specific disorders, increase consistency across disorders, implementing new principles like 
stronger emphasis on dimensional measures) Helzer et al. 2008; Wittchen et al. 1999. 
Unfortunately, gender issues are not always on the work agenda of DSM-V task forces. It 
should be mentioned that this dilemma is not unique to gender issues, but is equally shared, 
for example, by the age and developmental work groups. A particular challenging barrier 
might also be seen in the specific DSM-V rules for making revisions: For suggesting and 
introducing new disorders or major revisions the bar for successful adoption of a proposal is 
quite high. To mention a few: (a) There must be consensus in the task force and among 
advisors and experts for the change, (b) there must be substantial experimental and empirical 
evidence across all domains of the validation process (familial aggregation/ co-aggregation, 
genetics, neurobiological factors, sociodemographic and cultural factors, environmental risk 
factors, prior psychiatric history, cognitive emotional, temperament and personality, 
comorbidity, diagnostic stability, course of illness, response to treatment), and (c) among 
these causal neurobiologic factors are emphasized, consistent with DSM-V's mission to be a 
system that is stronger related to core pathogenetic processes rather than being simply 
descriptive and reliable. Clearly, providing such comprehensive validation evidence is 
sometimes even difficult for established diagnoses, even more so for new diagnostic 
categories or new diagnostic criteria proposed. The situation is even more challenging if one 
considers that there are considerable pressures to simplify the forthcoming DSM-V, for 
example, by reducing the number and the heterogeneity of diagnostic groups Helzer et al. 
2008. This incomplete description of the DSM-V revision process makes it evident how 
difficult it is and will always be to justify new syndromes and disorders as independent 
diagnoses or to achieve major modifications in the criteria. Accepting these standards more or 
less willingly means that, if we want a more comprehensive and specific consideration of 
female-specific criteria and disorders in the future classification, concerted action form 
researchers, clinicians, and stakeholders is mandatory. Furthermore, from a science 
perspective, there must be clear experimental and empirical evidence for all the changes 
proposed, presented in a way that makes it easy for the revision task forces to translate the 
evidence into explicit criteria.    
 
Heterogeneity and fragmentation of the women's mental health field – a barrier? 
 
Given that the women's mental health field is in fact well-organized with a broad consensus-
based agenda, one might be surprised to see fragmentation listed here as a barrier. It is 
certainly true –  as displayed in the Conceptual Framework (Surgeon General’s Workshop on 
Women’s Mental Health, Workshop Report 2005) – that this interdisciplinary field is much 
more organized than other fields. However, when it comes to revising a diagnostic system for 
mental disorders, the broad coverage of interdisciplinary topics ranging from lifestyle issues 
to social forces can also become an obstacle. Particularly, if many interdisciplinary fields with 
different concepts, definitions, and agendas are involved, the coherent work on a few selected 
issues in the field of diagnostic classifications and the elaboration of scientific evidence may 
become difficult. This seems to be especially true with regard to meeting the formal and 
content requirements of an empirically based pathogenetic classification system as outlined 
above as the core mission for DSM-V. For example, the term “women's mental health” covers 
an extremely broad spectrum of issues that go much beyond the core aspects of immediate 
relevance to diagnostic classification and criteria for disorders. The lack of a coherent 
framework of “women-specific diagnostic and classificatory issues” and the lack of a 
consensus-based “diagnostic classificatory proposal” from the women's mental health field 
that could provide guidance to DSM-V is clearly one core barrier. This lack becomes easily 
evident, if we would simply do a literature search in web of science or PubMed using the 
search terms “diagnostic classification and gender” as an example. Although one would 
expect that these search terms lead to hundreds of hits, one is surprised to find mostly 
references that deal with “gender identity disorders.” The reason for this is evident; the 
relevant literature is simply fragmented and listed under a range of other keywords, that rarely 
specifically used keywords like diagnostic classification, diagnosis, etc. Greater coherence, 
coordination, and emphasis on diagnostic issues and the derivation of a coordinated proposal 
as to how the women's mental health field would like to see female-specific issues considered 
in DSM-V would be a major step forward. Providing such a proposal, either in form of 
diagnostically cross-cutting or diagnosis-specific proposals, would make it easier for the 
DSM-V task forces to consider such changes seriously and more systematically. The 
collections of excellent papers in this issue highlight – with a few exceptions – this problem 
clearly. Most of the contributions focus on selected areas such as postnatal and perinatal 
depression or psychosis, trauma and posttraumatic stress disorder, and PMDD, making well-
substantiated suggestions for changes in various forms and formats. Yet, beyond postnatal 
mood disorder, there seems to be little consistency and agreement even among this specialist 
group about how such changes can be effectively translated and justified within the content of 
the ongoing DSM-V revision process. This failure might be due to the differences in traditions 
and procedures used in the interdisciplinary women's mental health field. As an example, one 
could highlight that, at this point, there is no consensus about the use of a comprehensive 
diagnostic assessment platform for female-specific issues in diagnostic classification that 
could help to build up over time a coherent symptom, syndrome, and diagnostic platform of 
evidence needed for a more successful translation of evidence into diagnostic classification 
systems.  
 
 
The need for a coherent female-specific diagnostic assessment platform 
 
Several authors have recently highlighted the problem that there are no standard diagnostic 
assessment tools that provide sufficiently detailed information about female-specific disorders 
such as PMDD, female-specific characteristics of psychopathological presentations such as 
mental disorders with postpartum onset, the relationship of characteristics of the menstrual 
cycle with psychopathology and perimenopausal and postmenopausal manifestations of 
syndromes (Soares and Zitek 2008; Steiner et al. 2003b; Yonkers and McCunn 2007). Given 
the increased psychopathological burden of women with regard to most diagnoses (Andrade 
et al. 2003), the lack of such an instrument has also impeded the accumulation of better 
clinical–epidemiological information regarding the core factors associated with the increased 
incidence and prevalence of the following mental disorders in women. Epidemiological 
studies consistently show that, with the onset of the reproductive years at menarche, mood 
disorders are at least twice as common in women as in men (Kessler 2003; Lewinsohn et al. 
1998; Steiner et al. 2003a; Wittchen and Jacobi 2005). A similar gender-specific pattern is 
also evident in anxiety, eating, and somatoform disorders as well as with regard to the type 
and extent of comorbid patterns (Rief et al. 2001; Wittchen and Jacobi 2005; Yonkers and 
McCunn 2007). There is also considerable evidence that onset, course, and prognosis of these 
disorders may be different for men and women (Fehm et al. 2005; Wittchen and Jacobi 2005). 
In spite of the existence of many syndrome-specific assessment tools, there are almost no 
generally agreed upon comprehensive psychopathological assessment instruments that fully 
address the specific characteristics of women's reproductive years. Therefore, it has been 
difficult to relate psychopathological syndromes and their course to core female-specific 
issues, such as the menstrual cycle, pregnancy, postpartum, and menopause (Steiner et al. 
2003a; Yonkers and McCunn 2007). Furthermore, some disorders that are exclusively 
relevant to women such as PMDD and perinatal and perimenopausal disorders are not covered 
by the existent standard diagnostic tools at all. Despite the wide range of instruments available 
that specifically address some of these critical issues, these tools are typically questionnaires 
covering only a few domains and cannot easily be embedded into one coherent and 
conceptually sound diagnostic assessment instrument along the principles of DSM-IV or 
DSM-V. Thus, except for some recent attempts to supplement established diagnostic 
instruments by female-specific diagnostic modules such as PMDD (Wittchen et al. 2002), 
there has been no instrument in this area covering a broader spectrum of women-specific 
mental disorders. Most recently, we have suggested the CIDI-VENUS (CIDI-V; Martini et al. 
2009; Steiner et al. 2003b; Steiner et al. 2007; Steiner et al. 2008; Wittchen et al. 2001) as 
such a – probably still incomplete and imperfect tool – providing a systematic and 
comprehensive approach to current female-specific core questions in mental disorders and 
psychopathological research, allowing a reliable examination of a wide range of mental 
disorders with embedded modular additions of women-specific conditions and factors 
(menstruation, pregnancy, postpartum, or menopause). The availability of a standardized and 
comprehensive categorical and dimensional examination of mental disorders and 
psychopathological syndromes during pregnancy as well as pregnancy and delivery outcomes 
(e.g., gestational age, mode of delivery) is expected to provide an extensive and solidly 
coordinated basis for cross-sectional and longitudinal studies in epidemiological and clinical 
settings. Linked to the already existent family-genetic CIDI version (Lieb et al. 2000), the 
instrument might also enhance the efficiency and the detail of studies dealing with the familial 
transmission of mental disorders as well as perinatal research in general. Although the CIDI-
V was primarily developed for epidemiological studies to examine women-specific disorders, 
it can also be used for clinical practice to study prevalence and incidence, maintenance, 
comorbidity patterns, and temporal relationships with the female reproductive cycle more 
comprehensively. The CIDI-V utility is enhanced by further covering critical issues like the 
impact of adverse pregnancy outcomes (e.g., stillbirth) and consequences of abdominal 
operations. Such approaches, if accepted more widely, might be instrumental for building up a 
cumulative data platform for female-specific issues in diagnostic classification, providing the 
basis for a more successful translation of evidence into future diagnostic classification 
systems.  
 
 
Conclusion 
 
A more successful translation of gender-specific issues into future diagnostic classification 
system requires concerted action form the women's mental health field specifically 
emphasizing those female-specific issues that should be considered in diagnostic 
classification systems. It is the responsibility of the women's mental health field to reach 
consensus and overcome fragmentation in order to propose specific suggestions according to 
the general rules of diagnostic classification systems and the specific rules used in the current 
DSM-V process. As long as such consensus is lacking or restricted to a few mental disorders 
only, it is unlikely that our vision of a broader and comprehensive recognition of female-
specific criteria in DSM-V and ICD-10 will become a reality.  
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